You are here

Article Text

Article menu
Download PDFPDF
Original article
Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish
  1. K Zahka1,
  2. K Kalidas2,
  3. M A Simpson2,
  4. H Cross3,
  5. B B Keller4,
  6. C Galambos5,
  7. K Gurtz6,
  8. M A Patton2,
  9. A H Crosby2
  1. 1
    Department of Pediatrics, Division of Cardiology, Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, Ohio, USA
  2. 2
    Clinical Developmental Sciences, St George’s University of London, London, UK
  3. 3
    Department of Ophthalmology, University of Arizona School of Medicine, Tucson, Arizona, USA
  4. 4
    Department of Pediatrics, Division of Pediatric Cardiology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA
  5. 5
    Department of Pathology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA
  6. 6
    Windows of Hope Genetic Studies, Kimmeridge Trail, Ohio, USA
  1. Dr A H Crosby, Medical Genetics Section, Clinical Developmental Sciences, St George’s University of London, Cranmer Terrace, London SW17 0RE, UK; acrosby{at}sgul.ac.uk

Abstract

Background: Familial hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death among young and apparently healthy people. Autosomal dominant mutations within genes encoding sarcomeric proteins have been identified. An autosomal recessive form of HCM has been discovered in a group of Amish children that is associated with poor prognosis and death within the first year of life. Affected patients experienced progressive cardiac failure despite maximal medical treatment. Postmortem histology showed myofibre disarray and myocyte loss consistent with refractory clinical deterioration in affected infants.

Objective: To conduct a genome-wide screen for linkage and try to identify an autozygous region which cosegregates with the infant cardiac phenotype

Methods and results: An autozygous region of chromosome 11 which cosegregates with the infant cardiac phenotype was identified. This region contained the MYBPC3 gene, which has previously been associated with autosomal dominant adult-onset HCM. Sequence analysis of the MYBPC3 gene identified a splice site mutation in intron 30 which was homozygous in all affected infants. All surviving patients with the homozygous MYBPC3 gene mutations (3330+2T>G) underwent an orthotopic heart transplantation.

Conclusions: Homozygous mutations in the MYBPC3 gene have been identified as the cause of severe infantile HCM among the Amish population.

https://doi.org/10.1136/hrt.2007.127241

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding: This study was supported by the Birth Defects Foundation New Life.

    • Competing interests: None.

    • Ethics approval: Approved by the local research ethics committee.